Biotech

All Articles

Editas profit Tip Cas9 licensing liberties for $57M

.Against the background of a Cas9 license battle that refuses to pass away, Editas Medication is act...

Ultragenyx changes genetics therapy dosing to dial up efficiency

.A minority of individuals taking Ultragenyx Pharmaceutical's Wilson health condition gene therapy U...

Biopharma unemployment rate maintains in Q3: Brutal Biotech analysis

.As summer months heat energy turns to cool down winds, hopes that this year would bring extensive f...

J &amp J loses stage 2 dengue applicant in most current switch from vaccines

.Johnson &amp Johnson's deprioritization of its transmittable condition pipeline has asserted one mo...

Relay loses 10% of personnel after earlier cutbacks in July

.Preciseness medicine biotech Relay Therapies is actually shedding about 10% of its labor force in i...

Pentixapharm ratings $22M IPO to advance radiopharma tests

.Pentixapharm has actually produced almost 20 thousand europeans ($ 22 thousand) coming from an IPO,...

Lundbeck taps Charles Stream for AI-enabled neuro medication breakthrough

.Lundbeck has actually tapped Charles River Laboratories' artificial intelligence capacities to assi...

Big pharma, biotech 'will not essentially be actually symbiotic' in artificial intelligence: S&ampP

.Huge Pharma is actually committing intensely in AI to reduce progression timelines and also foster ...

I &amp I biotech Triveni increases $115M for preclinical antibodies

.Triveni Bio has trapped $115 million in set B funds to advance preclinical antitoxin plans made to ...

IGM turns from cancer to autoimmune, shaking up C-suite

.IGM Biosciences finished last year laying off personnel and also simplifying its cancer cells pipe....